Jaina, Adryll R.
HRN: 23-83-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
MUPIROCIN 2%, 15G (TUBE)
10/18/2023
10/25/2023
TOPICAL
15g
BID
Neonatal Sepsis; Omphalitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes